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09:00
12:00-12:15
12:15-13:15
Registration Opens
Opening Remarks and Welcome
(OARSI President and President Elect: Sergio Jimenez and Roland Moskowitz)
Plenary Session I
Chair: S. Jimenez and R. Moskowitz
12:15-12:50 [M1] Osteoarthritis in China and USA: A comparison of prevalence and risk factors.
M. Nevitt
12:50-13:00 Questions and discussion
13:00-13:10 [M2] Validation of the OARSI responder criteria: Responders have better overall health status
than nonresponders
M. Hochberg
13:15-1400
14:00-1530
15:30-16:00
16:00-17:30
Lunch
Symposium 1: Towards a better management of Osteoarthritis. Is there a rationale for
cyclo-oxygenase inhibitors? (Sponsored Symposium)
Chairs: F. Wollheimand S. Abramson
14:00-14:25 [M3] Inflammation in osteoarthritis: Targets for therapy
S. Abramson
14:25-14:30 Questions and discussion
14:30-14:40 [M4] Interleukin-17 regula1es the level and stability of cyclooxygenase-2 (COX-2) mRNA through
specific activation of the p38 mitogen-activated protein kinase cascade in target cells. Role of
AU-rich sequences in the 3' untranslated region (UTR) of COX-2 mRNA
W Faour
14:40-14:45 Questions and discussion
14:45-14:55 [M5] AZD3582: Analgesic efficacy and gastrointestinal safety in rats
S. Lohmander
14:55-15:00 Questions and discussion
15:00-15:10 [M6] Effects of SC-560, SC-58125 and diclofenac on expression and synthesizing activity of COX-1
and COX-2 in synovitis tissue in osteoarthritis
H. Knorth
15:10-15:15 Questions and discussion
15:15-15:25 IM7] A subgroup analysis by joint of the efficacy of Rofecoxib versus Naproxen in osteoarthritis:
From the "Advantage" trial
M. Schulz
Break
Symposium 2: Towards a Better Management of Osteoarthritis. Is There a Place for
Nutraceuticals and Dietary Supplements?
Chairs: P. Ghosh and R. Altman
16:00-16:25 [M8] Integrative medicine - a maturing science
R. Moskowitz
16:25-16:30 Questions and discussion
16:30-16:40 [M9] Discovery and evaluation of potential disease modifying anti-osteoarthritis drugs using surface
plasmon resonance technology
B. Shen
16:40-16:45 Questions and discussion
ix
x16:45-16:55 [M10)
16:55-17:00
17:00-17:10 [M11)
17:10-17:15
17:15-17:25 [M12)
17:25-17:30
19:00-20:30
Scientific Program
Matrix metalloprotease 1,3,13, nitric oxide and prostaglandin E2 production from OA
chondrocytes and synoviocytes stimulated by interleukin-1 - suppresive effects of glucosamine
H. Nakamura
Questions and discussion
Topical glucosamine and chrondroitin sulfate for osteoarthritis of the kne: A randomised con-
trolled style
M. Cohen
Questions and discussion
Supplementary vitamin E does not affect the loss of cartilage volume in knee osteoarthritis: A 2
year double-blind randomised placebo controlled study
A. Wluka
Questions and discussion
OARSI Opening Reception
Australian National Maritime Museum
Monday
23 September
2002
09:00-10:30
09:00-10:30
10:30-11 :00
11 :00-11 :10
All posters should be mounted by the evening of 22nd September
Poster Chairs: M. Smith and R. Day
PS1-PS6: Osteoarthritis and Bone
PS7-PS12: Cartilage Morphology
PS13-PS23: Biomechanics
PS24-PS31: Cartilage Repair
PS31-PS59: Chondrocyte Metabolism
PS60-PS71: Genetics and Gene Expression
PS72-PS83: Matrix Turnover
PS84-PS92: Osteoarthritis and Synovium
PS93-PS109: Animal Models
PS110-PS124: Imaging
PS125-PS170: Clinical Assessments and Treatments
Poster Session and Continental Breakfast
Plenary Session II
Chairs: 1. Kimura and L. Sandell
09:00-09:35 [M13) How can gene array and proteomics help us to understand the pathogenesis of osteoarthritis?
A. Amin
09:35-09:45 Questions and discussion
09:45-09:55 [M14) Altered gene expression in osteoblast-like MG-63 cells subjected to cyclic hydrostatic pressure
V. Tasevski
10:10-10:15 Questions and discussion
10:00-10:10 [M15) Suppression of chrondrocyte-characteristic gene expression by IL-1 is mediated
through the transcription factor C/EBP
L. Sandell
10:10-10:15 Questions and discussion
10:15-10:25 [M16) Differentially expressed genes in human articular cartilage
K. Marshall
10:25-10:30 Questions and discussion
Break
Open Session 1 - Animal Models
Chairs: M. Goldring and C. Handley
11 :00-11 :10
11 :10-11 :15
[M17) Osteoarthritis in the biglycan/fibromodulin double deficient mouse is associated with increased
leavel of cartilage oligomeric matrix protein and decreased levels of decorin and type II colla-
gen in the articular cartilage
L. Ameye
Questions and discussion
Osteoarthritis and Cartilage Vol. 10 Supp. 10A xi
11 :15-11 :25 [M18]
11 :25-11 :30
11 :30-11 :40 [M19]
11 :40-11 :45
11 :45-11 :55 [M20]
11 :55-12:00
Long term high-dose ascorbic acid intake in the Hartley guinea pig increases spontaneous
osteoarthritis severity
V. Kraus
Questions and discussion
Quantitative in vivo magnetic resonance imaging to assess disease modification in the guinea
pig model of osteoarthritis
R. Maciewicz
Questions and discussion
Surface-active phospholipid: Deficiency in osteoarthritic joints, use to revse joint degeneration
in horses and its lubrication of implanted prostheses
B. Hills
Questions and discussion
12:00-13:30
13:30-15:30
15:30-16:00
16:00-17:00
17:00
Tuesday
24 September
2002
07:30-09:00
Lunch
Symposium 3: Osteoarthritis (OA) and the Postmenopausal Female
Chairs: P. Sambrook and R. Loeser
13:30-14:00 [M21] Epidemiological, MRI and radiological findings
F. Cicuttini
14:00-14:05 Questions and discussion
14:05-14:34 [M22] Estrogen receptor signalling in OA chondrocytes
C. Carlson
14:35-14:40 Questions and discussion
14:40-15:10 [M23] Hormonal modulation of osteoclast activity in OA
S. Goldring
15:10-15:15 Questions and discussion
15:15-15:25 [M24] Ovariectomy increase nitric oxide production in ovine patellar cartilage
M. Cake
15:25-15:30 Questions and discussion
Break
Open Session 2: Clinical Assessment in OA
Chair: J.-Y. Reginster and N. Bellamy
16:00-16:10 [M25] Reproducibility of fixed-flexion knee radiography in osetoarthritic patients
y. Miaux
16:10-16:15 Questions and discussion
16:15-16:25 [M26] Magnetic resonance imaging of knee joint using high field 8 Tesla system
A. Kangarlu
16:25-16:30 Questions and discussion
16:30-16:40 [M27] Muscle force in osteoarthritis of the knee
M. Fransen
16:40-16:45 Questions and discussion
16:45-16:55 [M28] Comparison of cartilage morphology in professional weightlifters and sprinters with normal
volunteers suggests that human articular cartilage cannot adapt to mechanical stimulation
C. Gratzke
16:55-17:00 Questions and discussion
Evening Free
Poster Session and Continental Breakfast
09:00-11 :00
09:00-09:35
09:35-09:45
Plenary Session III
Chairs: M. Lotz and F. Berenbaum
[M29] Modulation of chondrocyte phenotype in the initiation and progression of osteoarthritis
T. Aigner
Questions and discussion
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09:45-09:55 [M30] Proeolysis of type IX collagen and loss of biglycan, decorin and fibromodulin in progressive
articular cartilage degradation
C. Little
09:55-10:00 Questions and discussion
10:00-10:10 [M31] Multiple interacting IL-induced transcription factors converge to suppress constitutive COL2A1
promoter activity
M. Goldring
10:10-10:15 Questions and discussion
10:15-10:25 [M26] Facilitated glucose transport and chondrocyte activation
A. Shikhman
10:25-10:30 Questions and discussion
10:30-10:40 [M33] Microsomal prostaglandin E synthase is expressed in human chondrocytes under regulation
by interleukin-1 via the P38 mitogen-activated protein kinase signalling pathway in an
isoform-specific manner
F. Berenbaum
10:40-10:45 Questions and discussion
10:45-10:55 [M34] Articular chondrocyte proliferation and cyclin D expression
M. Stewart
10:55-11 :00 Questions and discussion
11 :00-11 :30 Break
11 :30-12:30 Young Investigators Awardee Presentations
Chairs: S. Jimenez and R. Moskowitz
Difference in early expression of c-tosgene via increase of intracellular Ca2 + ion reflects
repair potentials of superficial defects on articular cartilage in fetal and adult rats
N. Kumahashi
Questions and discussion
Suppression of cell death and OA progression by inhibiting intracellular p38 MAP kinase in
chondrocytes: In vitroand in vivo evidence
L. Wei
Questions and discussion
Adenoviral overexpression of TGF-BMP inhibitors during experimental osteoarthritis
A. Scharstuhl
Questions and discussion
Predictors for the incidence and progression of lumbar spine intervertebral disc degeneration:
The Chingford study
G. Hassett
Questions and discuissions
Lunch
Symposium 4: Repair and Regeneration of Articular Cartilage: Potential Applications in
Ostgeoarthritis
Chairs: S. Lohmander and D. Sonnabend
11 :30-11 :40 [M35]
11 :40-11 :45
11 :45-11 :55 [M36]
11 :55-12:00
12:00-12:10 [M37]
12:10-12:15
12:15-12:25 [M38]
12:25-12:30
12:30-14:00
14:00-16:00
14:00-14:30 [M39] Chondrocytes or stem cells?
B. Johnstone
14:30-14:35 Questions and discussion
14:35-15:05 [M40] How important is the biomatrix/scaffold for cartilage regeneration?
G. Vunjak-Novakovi
15:05-15:10 Questions and discussion
15:10-15:40 [M41] Animal studies and clinical outcomes
J. Buckwalter
15:40-15:45 Questions and discussion
15:45-15:55 [M42] Repair of articular cartilage lesions with polyactive™ 70/30 and polyactive 55/45 in rabbits:
With and without allogeneic chondrocytes
R. Kuijer
15:55-16:00 Questions and discussion
Osteoarthritis and Cartilage Vol. 10 Supp. 10A xiii
16:00-16:30
19:00-23:00
Wednesday
25 September
2002
07:30-09:00
09:30-1 0:00
10:00-12:00
10:00-10:35
10:35-10:45
10:45-10:55 [M43]
10:55-11:00
11 :00-11 :10 [M44]
11 :10-11 :15
11 :15-11 :25 [M45]
11 :25-11 :30
11 :30-11 :40 [M46]
11:40-11:45
11 :45-11 :55 [M47]
11 :55-12:00
12:00-12:30
12:30-14:00
14:00-16:00
Break
OARSI Harbor Cruise and Gala Dinner
Poster Session and Continental Breakfast
Break
Plenary Session IV
Chairs: G. Nuki and L. Sharma
The origin of pain in oesteoarthritis and strategies for therapeutic intervention
B. Kidd
Questions and discussion
Mechanism of pain reduction by hyaluronan derivatives (Hylans)
C. Belmonte
Questions and discussion
Pain relief is not a confounder in joint space narrowing assessment of full extension knee
radiographs
K. Pavelka
Questions and discussion
Cartilage defects, subchondral bone marrow changes, pain and knee osteoarthritis
M. Sowers
Questions and discussion
Immediate effects of adhesive tape on pain and physical impairments in individuals with knee
osteoarthritis
R. Hinman
Questions and discussion
OMERACT-OARSI initiative: OARSI set of responder criteria for osteoarthritis (OA) clinical
trials revisited
T. Pham
Questions and discussion
OARSI Business Meeting
Lunch
Symposium 5: Structural Modification in Osteoarthritis (OA): How Can it be Assessed
and can it be Influenced by Therapeutic Agents?
16:00
14:00-14:30 [M48] The OA initiative: Where are we now and where are we going?
G. Lester
14:30-14:35 Questions and discussion
14:35-15:05 [M49] Quantitative morphological assessment of cartilage in OA by MRI
F. Eckstein
15:05-15:10 Questions and discussion
15:10-15:45 [M50] Structural modification in OA by drugs (SMOADS): Has it been achieved yet?
J. -Y. Reginster
15:40-15:45 Questions and discussion
15:45-15:55 [M51] Isomerized aggrecan fragments are released during cartilage degradation and can be
measured in serum
S. Christgau
15:55-16:00 Questions and discussion
OARSI 2002 Congress Concludes
